Brief: Enorama Pharma Postpones Its 2025 Year-End Report
13/02/2026 11:02
Feb 13 (Reuters) - Enorama Pharma AB ERMA.ST: POSTPONES PUBLICATION OF ITS 2025 YEAR-END REPORT Source text: ID:nWkr4xtjgj Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO